Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in a patient with antiphospholipid antibodies and Charcot-Marie-Tooth disease

Intern Med. 2011;50(5):487-93. doi: 10.2169/internalmedicine.50.4300. Epub 2011 Mar 1.

Abstract

A 26-year-old woman with a history of mild mental retardation, Charcot-Marie-Tooth disease (CMT) and idiopathic thrombocytopenic purpura developed severe thrombocytopenia with Coombs-negative hemolytic anemia. Magnetic resonance imaging revealed a fresh cerebral infarction in the left precentral gyrus. ADAMTS-13 deficiency caused by an inhibitor and anti-cardiolipin antibodies were detected in the blood. After treatment with prednisolone and fresh frozen plasma, ADAMTS-13 activity was normalized, the ADAMTS-13 inhibitor had disappeared and the thrombocytopenia with a bleeding tendency was improved. To our knowledge, this is the first case of thrombotic thrombocytopenic purpura caused by ADAMTS-13 deficiency associated with antiphospholipid antibodies and CMT.

Publication types

  • Case Reports

MeSH terms

  • ADAM Proteins / antagonists & inhibitors
  • ADAM Proteins / blood
  • ADAM Proteins / deficiency*
  • ADAMTS13 Protein
  • Adult
  • Antibodies, Anticardiolipin / blood
  • Antiphospholipid Syndrome / blood
  • Antiphospholipid Syndrome / complications*
  • Antiphospholipid Syndrome / immunology
  • Charcot-Marie-Tooth Disease / complications*
  • Charcot-Marie-Tooth Disease / immunology
  • Female
  • Humans
  • Plasma
  • Platelet Transfusion
  • Prednisolone / therapeutic use
  • Purpura, Thrombotic Thrombocytopenic / blood
  • Purpura, Thrombotic Thrombocytopenic / etiology
  • Purpura, Thrombotic Thrombocytopenic / immunology
  • Purpura, Thrombotic Thrombocytopenic / therapy

Substances

  • Antibodies, Anticardiolipin
  • Prednisolone
  • ADAM Proteins
  • ADAMTS13 Protein
  • ADAMTS13 protein, human

Supplementary concepts

  • Thrombotic thrombocytopenic purpura, acquired